September 26-28, 2013
Chicago Marriott Downtown Magnificent Mile
Chicago, IL, USA
Course Overview/Statement of Need:
Heart disease accounts for more fatalities than any other single cause or group of causes of death in the United States. Valvular heart disease, affecting over 5 million individuals in the United States alone, can be congenital or acquired and may or may not be symptomatic for patients. While national Guidelines inform the care, controversies in care within advancing technological and medical arenas demand collaborative methods of diagnosis and strategies for medical, surgical and interventional management. The American College of Cardiology and the American Association for Thoracic Surgery are once again partnering to bring together cardiologists and surgeons in a cooperative, case-based course to address the rapid advances in the treatment of valvular heart disease. With the tradition of interactivity and practical decision making, the unique Heart Valve Summit is designed to engage participants in discussions, debates and potential controversies surrounding real-world cases with renowned faculty on the cutting edge of clinically relevant data for valvular heart disease management.
This interdisciplinary course emphasizes clinical decision making while combining the most relevant medical, surgical and interventional options for patient care. Tools for management are rapidly advancing and can significantly impact the entire care team. Breakout sessions for cardiologists, cardiac surgeons, nurses and physician assistants are designed to help specialists manage their unique challenges from a team perspective.
The overall goal of this course is to enhance knowledge and ultimately improve competency in the practice of managing valvular heart disease.
Upon completion of this course, attendees should be able to —
- Discuss with colleagues and patients the options available for patients presenting with valvular heart disease
- Design a strategy for management of patients presenting with various valve diseases and comorbid challenges
- Assess advantages and limitations of medical, surgical and interventional therapies based on individual case parameters and accepted guidelines
- Compare and contrast the usefulness and limitations of imaging techniques in valvular heart disease
- Critically evaluate data to determine whether local expertise and accessibility are conducive to optimal patient care and if the patient should be referred
- Review the best practice guidelines for optimal surgical timing to improve patient outcomes
This course is intended for cardiologists, interventional cardiologists, cardiothoracic surgeons, internists, nurses, physician assistants and all health care professionals involved in the evaluation, diagnosis and/or management of patients with valvular heart disease.
David H. Adams, MD, The Mount Sinai Medical Center
Steven F. Bolling, MD, University of Michigan Health System
Robert O. Bonow, MD, Northwestern University Feinberg School of Medicine
Howard C. Herrmann, MD, University of Pennsylvania Health Center
Michele Langenfeld, RN, MS, Northwestern Memorial Hospital